Health
Novo Nordisk Has a Weight-Loss Pill But Can’t Make It Yet
- Lilly, Pfizer, other rivals working toward oral medications
- Novo already short of main ingredient for weight-loss shots
This article is for subscribers only.
Novo Nordisk A/S has a successor waiting in the wings for the generation of weight-loss shots it pioneered: a pill that helps people shed pounds without the drawbacks of an injection.
The medicine is the next frontier in the obesity fight, promising further billions in revenue, and Novo is leading once again. Trouble is, it can’t launch the drug widely without endangering its existing best-sellers.